Rocket Pharmaceuticals Inc. (RCKT) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Rocket Pharmaceuticals In...

NASDAQ: RCKT · Real-Time Price · USD
3.26
0.07 (2.19%)
At close: Sep 26, 2025, 3:59 PM
3.25
-0.44%
After-hours: Sep 26, 2025, 06:08 PM EDT

Rocket Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
163.63M 55.9M 140.52M 232.69M
Short-Term Investments
208.7M 317.27M 215.88M 156.05M
Long-Term Investments
1.36M 34.32M 43.28M 1.34M
Other Long-Term Assets
529K 1.91M 1.95M 1.8M
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
5.85M 5.05M 7.67M n/a
Total Current Assets
378.18M 378.22M 364.06M 392.06M
Property-Plant & Equipment
83.32M 87.59M 77.64M 72.35M
Goodwill & Intangibles
64.3M 64.3M 64.88M 30.82M
Total Long-Term Assets
149.52M 188.12M 187.75M 104.96M
Total Assets
527.7M 566.34M 551.81M 497.02M
Account Payables
1.63M n/a n/a n/a
Deferred Revenue
n/a n/a -36.66M -482
Short-Term Debt
n/a 2.72M 2.51M 2.55M
Other Current Liabilities
36.2M 7.21M 39.67M 11.93M
Total Current Liabilities
40.68M 48.51M 39.17M 22.17M
Long-Term Debt
n/a 22.33M 20.36M 20.05M
Other Long-Term Liabilities
1.14M 2.94M 2.6M 80K
Total Long-Term Liabilities
23.78M 25.26M 22.95M 20.13M
Total Liabilities
64.47M 73.77M 62.12M 42.3M
Total Debt
25.5M 25.04M 22.87M 22.6M
Book Value
463.23M 492.57M 489.69M 454.72M
Book Value Per Share
4.89 5.86 7.19 7.19
Common Stock
1.06M 903K 791K 645K
Retained Earnings
-1.22B -959.37M -713.77M -491.91M
Comprehensive Income
66K 319K -357K -161K
Shareholders Equity
463.23M 492.57M 489.69M 454.72M
Total Investments
208.7M 351.59M 259.15M 156.05M